- About CR&T
- Contact Us
- Friends of CR&T
- Mission Statement
- Newsletter Sign Up
- Our Leadership
- Our Story
- Terms & Conditions
- Amazon Smile
- CR&T Remembers Keith Muhleman
- Dr. Silver's Corner
- Featured Patient Stories
- Free Prostate Screening in Queens, NY
- Friends of CR&T
- In The News
- Maybe It Was a Chicken
- MPN & Cancer Research Newsletter
- Share Your Story
- Social Media
- Stay Up To Date with CR&T Cancer Research & Treatments
- Using Interferon as a Therapy in the Treatment of MPNs
Funding Cancer Research
- Making a Cancer Research Donation
- Supporting Cancer Research Funding
- Why You Should Donate to Cancer Research
Hall of Fame Event
- Cancer Survivor Honorees
- Hall of Fame Event
- Hall of Fame Gallery
- Hall of Fame Honoree, Peter Criss, on Surviving Breast Cancer
- Humanitarian Honorees
- Lifetime Achievement Honorees
- Past Honorees
- Test Standard Page
International Patient Symposium
- 10th International Patient Symposium on Myeloproliferative Neoplasms
- 10th International Patient Symposium on Myeloproliferative Neoplasms - Program
Medical Advisory Board
- Alexander J. Swistel, M.D.
- Andrew I. Schafer, M.D.
- Anne Moore, M.D.
- David A. Scheinberg, M.D., Ph.D.
- Edward P. Ambinder, M.D.
- Jerry L. Spivak, M.D.
- John P. Leonard, M.D.
- Linda T. Vahdat, M.D.
- Malcolm Moore, D. Phil
- Mark Pasmantier, M.D.
- Medical Advisory Board
- Morton Coleman, M.D., FACP
- Richard T. Silver, M.D., FACP
- Shahin Rafii, M.D.
Our Research Impact
- Breast Cancer and Copper Deficiency
- Development of Interferon in MPN Therapy
- Effects of MPNs on Blood Flow in the Brain
- Identification of Mechanism for Resistance to Ibrutinib in Lymphoma
- Our Research Impact
- Research Stories
- 8th International Patient Symposium on Myeloproliferative Neoplasms Videos
- 9th International Patient Symposium on Myeloproliferative Neoplasms Videos
- Biomarkers and Molecular Abnormalities: What Do Patients Need to Know?
- Can Genetic Analysis Predict MPN Progression?
- Can We Prevent Progression of the MPNs with Interferon?
- Common Complications of the MPNs
- Current Developments in Myelofibrosis Treatment
- Current Developments in Polycythemia Vera Treatment: Is It Curable?
- Current Developments in Stem Cell Transplantation in the MPNs
- Current Management of Essential Thrombocythemia
- Current Management of Myelofibrosis
- Current Management of Polycythemia Vera
- Essential Thrombocythemia: Pathogenesis and Management
- Genetics of MPNs: From Initiation to Progression
- Laboratory Approaches to Studying MPNs
- Natural History and Heredity
- New Concepts in Basic Biology of MPNs
- Should I Take Aspirin, Plavix or Coumadin?
- Summary of Drugs in Current and Future Clinical Trials
- Update on JAK2 Inhibitors
- What Can I Expect from My MPN Treatment?
- What Can We Expect from My MPN Treatment
- What is the Clinical Trial Process?
- What is the Value of Epigenetic Therapy in MPN Treatment
- What Should You Expect from Your MPN Treatment?